ArticleJapanese journal of radiology2026
Whole-body CT characteristics of patients with severe fever with thrombocytopenia syndrome.
Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo characterize the computed tomography (CT) features of severe fever with thrombocytopenia syndrome (SFTS) and to identify imaging features predictive of an adverse prognosis. MATERIALS AND
methodsThirty-one patients diagnosed with SFTS between July 2017 and August 2025 and who underwent whole-body CT (17 men, 14 women; mean age, 75.3 years; 24 survivors, 7 non-survivors) were retrospectively reviewed. CT findings of the chest, abdominal organs, and regional lymph nodes were assessed. Initial CT scans (n = 31) were obtained a mean of 3.8 days (range, 0-7) after symptom onset, and follow-up CT scans (n = 20) were performed in 17 patients a mean of 6.0 days (range 1-18) after the initial scan, giving a total of 51 examinations. Additionally, for three cases in which autopsy was performed, correlation analysis was performed between the CT findings and pathological findings.
resultsOn initial CT, the most frequent finding was regional lymphadenopathy (n = 30, 96.8%), most commonly involving inguinal (n = 17, 54.8%) and axillary nodes (n = 11, 35.5%). Perinodal fat stranding was observed in 29 patients (93.5%). The most common thoracic finding was ground-glass opacity (GGO) (n = 17, 54.8%), followed by bronchial wall thickening (n = 16, 51.6%) and interlobular septal thickening (n = 15, 48.4%). Among abdominal organs, splenomegaly was the most frequent finding (n = 25, 80.6%), followed by renal enlargement (n = 15, 48.4%). On follow-up CT, the most frequently observed changes compared with the initial CT were increased renal volume (n = 17, 85%) and increased hepatic volume (n = 14, 70%). GGO was significantly more frequent in non-survivors than in survivors.
conclusionsCharacteristic CT findings of SFTS include regional lymphadenopathy with perinodal fat stranding, followed by splenomegaly and GGO. GGO may be an imaging finding predictive of an adverse prognosis.
Indexed as
Identifiers
42384330What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.